We leverage our deep kinase expertise to discover, optimize and develop a sustainable pipeline of small molecule kinase inhibitors. Learn about our candidates for cancer and other diseases with unmet medical need.
More About Our Pipeline» More About Our Clinical Trials»Our existing collaborations provide a strong endorsement of the benefits offered by our expertise in kinase drug discovery. Click below to learn more about the many ways to collaborate with Ambit.
More About Our Partnering Strategy»More About Our Partnerships»Click here to view the Ambit company presentation at the 30th annual JP Morgan Healthcare Conference in San Francisco on January 12th. Here you will find the latest overview of our pipeline and corporate highlights.
